Actress Christina Applegate, aged 54, is currently investigating the potential connection between her breast implants and the ongoing pain and fatigue she experiences, following her recent revelation of being misdiagnosed with multiple sclerosis (MS) in 2021.
During the November 10 episode of MeSsy, the podcast she co-hosts with Jamie-Lynn Sigler, Applegate, who rose to fame in the popular sitcom Married With Children, mentioned that she received a study indicating that symptoms associated with breast implants can mimic those of MS.
“I swear, for the past five years, I kept thinking, ‘What if they’re leaking and poisoning me?'” she stated, expressing her intention to discuss this concern with her medical team.
-
As Christina Applegate reveals MS misdiagnosis, doctor warns of wrong treatment risks
-
The subject of Lyme disease is littered with misinformation. Celebrities are part of the problem, experts say
Applegate had a double mastectomy and breast reconstruction in 2008 after being diagnosed with an early stage of breast cancer and testing positive for a BRCA1 gene mutation, which increases the risk of breast and other cancers. On her podcast, she remarked that she is “way overdue” for a replacement of her implants.
She has also shared her struggles with escalating pain and limited mobility in her right shoulder, stating it can take her at least 10 minutes to sit up and get out of bed. These symptoms are particularly challenging for her as “there are so many different things that could be happening.”
This inquiry follows her doctors informing her in October that she does not have MS. Applegate expressed that this news has left her back at “Square 1,” as her physical challenges persist and she is undergoing evaluations for other potential diagnoses, including rheumatoid arthritis, lupus, and Lyme disease.
While the underlying cause of Applegate’s symptoms is yet to be determined, breast implants have been linked to health issues in certain instances, although the specifics of the condition remain unclear.
Understanding Breast Implant Illness

Breast implant illness, or BII, describes symptoms reported by some individuals with implants, including fatigue, cognitive changes, joint pain, and muscle pain. This image features a Biocell textured breast implant by Allergan. (Nicolas Amaya/CBC)
Breast implant illness, commonly referred to as BII, encompasses symptoms experienced by certain individuals with breast implants.
As of December 31, 2025, Health Canada had documented 663 reports of symptoms or illnesses linked to breast implants — approximately one report for every 1,025 implants sold in Canada.
Fatigue emerged as the most commonly reported symptom, followed by mood fluctuations, gastrointestinal issues, and cognitive alterations. These reports are not confirmed cases; Health Canada states that the available data cannot determine whether implants are the cause of these symptoms, as they may stem from other sources.
The U.S. Food and Drug Administration (FDA) indicates that BII is not an officially recognized medical diagnosis and lacks a specific testing method. Reports of symptoms such as fatigue and joint discomfort do not clarify how frequently they occur or if they are implant-related.
Julie Elliott, a patient advocate, licensed practical nurse, and Canadian representative for the Breast Implant Safety Alliance (BISA), who claims she was diagnosed with autoimmune/inflammatory syndrome induced by adjuvants (ASIA syndrome) due to her breast implants, informed CBC News that some symptoms reported by individuals with implants can overlap with MS symptoms.
-
National breast implant registry much needed but long overdue, patients and doctors say
-
Alberta women with breast implant illness urge doctors to warn others of risk
“Chronic fatigue, memory issues, concentration difficulties, numbness, tingling, nerve pain, muscle weakness, hair loss, and others — these are akin to MS symptoms,” Elliott explained.
However, she cautioned against jumping to conclusions regarding Applegate’s implants being the cause. “I’m not suggesting that Christina Applegate’s breast implants are the reason for her symptoms,” she clarified, stating that it would be “premature and irresponsible” to assume they are the explanation.
“Similar symptoms do not automatically signify the same diagnosis,” Elliott noted. “Everything should be thoroughly examined and not dismissed without proper medical investigation.”

Christina Applegate, left, attends the 29th Screen Actors Guild Awards in Century City, California, on February 26, 2023. (Valerie Macon/AFP/Getty Images)
Dr. Stephen Nicolaidis, a plastic surgeon in Montreal who has treated over 1,500 patients seeking implant removal, also highlighted the necessity of looking into other potential causes.
He described BII as a “diagnosis of exclusion,” indicating that patients must undergo thorough evaluations, and if no alternative causes are identified, the possibility that implants may be contributing to the issues should be considered.
Nicolaidis noted that common symptoms reported include fatigue, hair loss, skin rashes, respiratory difficulties, joint and muscle pain, sleep disturbances, and cognitive fog. Some of these can overlap with symptoms linked to autoimmune diseases.
Referring to the symptoms Applegate has publicly shared, he mentioned, “Those symptoms she has could very well be related to her breast implants.” However, the exact cause of BII remains unclear, and he stated that researchers are still seeking definitive answers on how implants might contribute to these symptoms.
There is no conclusive test available to diagnose BII, Nicolaidis pointed out. Imaging may reveal silicone outside an implant, but he clarified that this finding is not necessary for someone to report symptoms. He also emphasized that BII is distinct from implant-associated lymphoma, a type of cancer tied to specific textured implants.
Rupture, Removal, and Future Steps
A rupture or leak represents a different issue from BII. The FDA identifies rupture and deflation as potential complications of implants and recommends that patients consult their healthcare provider about any new or unusual breast changes.
In a similar vein, Health Canada advises individuals with implants to routinely check for any unusual breast changes and to discuss any signs or symptoms with their physician. Decisions regarding the retention, replacement, or removal of implants should be made in consultation with a healthcare professional, considering individual symptoms, potential causes, and surgical risks, according to the agency’s recommendations.
The agency does not advocate for preventive implant removal due to the associated surgical risks and encourages individuals experiencing symptoms to discuss their concerns with a healthcare provider.
-
Struggling with pain for years, N.S. woman heads to Montreal for breast implant removal
-
Video
The costly, complex and dangerous world of removing medical devices | The Implant Files
Nicolaidis recommended that individuals with symptoms pursue a comprehensive medical assessment. He mentioned that if no other causes are identified, they can then explore whether the implants may be contributing factors and discuss options with their healthcare providers.
He ceased placing breast implants in 2021, believing that their risks outweighed the benefits in many situations, and now primarily focuses on implant removal. He added that removal does not guarantee a cure; some patients he has treated for MS have reported only marginal improvement, and individuals with diagnosed autoimmune conditions may still require medical treatment post-explant surgery.
Elliott expressed her belief that symptoms related to implants should be taken seriously, while recognizing that their origins are not entirely understood. She encouraged patients to seek balanced, evidence-based information and keep a record of any health changes.
“The absence of complete answers does not justify dismissing women’s experiences,” she stated.
